As previously noted, resolving the cognitive-CRP may require consideration of the spatial patterning of lesions with simultaneous evaluation of other aspects of MS pathology that may be both phenotypically relevant and independent from the burden of white matter hyperintensities [76, 77]. The gene discussed is CRP; the disease is myeloid sarcoma.